Peter Rossing

Peter Rossing

Clinical Professor

Member of:

  • Internal Medicine: Endocrinology

ORCID: 0000-0002-1531-4294

Publication year:
All
151 - 175 out of 509Page size: 25
  1. 2022
  2. Published

    KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease

    de Boer, I. H., Rossing, P., Caramori, M. L., Chan, J. C. N., Heerspink, H. J. L., Hurst, C., Khunti, K., Liew, A., Michos, E. D., Navaneethan, S. D., Olowu, W. A., Sadusky, T., Tandon, N., Tuttle, K. R., Wanner, C., Wilkens, K. G., Zoungas, S., Jadoul, M., Winkelmayer, W. C., Tonelli, M. A. & 7 others, Craig, J. C., Strippoli, G. F. M., Tunnicliffe, D. J., Higgins, G. Y., Natale, P., Cooper, T. E. & Willis, N. S., 2022, In: Kidney International. 102, 5, p. S1-S127 127 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  3. Published

    Kidney oxygenation, perfusion and blood flow in people with and without type 1 diabetes

    Laursen, J. C., Søndergaard-Heinrich, N., Haddock, B., Rasmussen, I. K. B., Hansen, C. S., Larsson, Henrik Bo Wiberg, Groop, P., Bjornstad, P., Frimodt-Møller, M., Andersen, U. B. & Rossing, Peter, 2022, In: Clinical Kidney Journal. 15, 11, p. 2072-2080 9 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  4. Published

    Liraglutide Lowers Palmitoleate Levels in Type 2 Diabetes: A Post Hoc Analysis of the LIRAFLAME Randomized Placebo-Controlled Trial

    Wretlind, A., Zobel, E. H., De Zawadzki, A., Ripa, Rasmus Sejersten, Curovic, V. R., Von Scholten, B. J., Mattila, I. M., Hansen, T. W., Kjær, Andreas, Vestergaard, H., Rossing, Peter & Legido-Quigley, C., 2022, In: Frontiers in Clinical Diabetes and Healthcare. 3, 8 p., 856485.

    Research output: Contribution to journal › Journal article › Research › peer-review

  5. Published

    Making an impact on kidney disease in people with type 2 diabetes: the importance of screening for albuminuria

    McGill, J. B., Haller, H., Roy-Chaudhury, P., Cherrington, A., Wada, T., Wanner, C., Ji, L. & Rossing, Peter, 2022, In: BMJ open diabetes research & care. 10, 4

    Research output: Contribution to journal › Review › Research › peer-review

  6. Published

    Management of Hyperglycemia in Type 2 Diabetes, 2022. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

    Davies, M. J., Aroda, V. R., Collins, B. S., Gabbay, R. A., Green, J., Maruthur, N. M., Rosas, S. E., Del Prato, S., Mathieu, C., Mingrone, G., Rossing, Peter, Tankova, T., Tsapas, A. & Buse, J. B., 2022, In: Diabetes Care. 45, 11, p. 2753-2786 34 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  7. Published

    Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

    Davies, M. J., Aroda, V. R., Collins, B. S., Gabbay, R. A., Green, J., Maruthur, N. M., Rosas, S. E., Del Prato, S., Mathieu, C., Mingrone, G., Rossing, Peter, Tankova, T., Tsapas, A. & Buse, J. B., 2022, In: Diabetologia. 65, 12, p. 1925-1966 42 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  8. Published

    Microalbuminuria Constitutes a Clinical Action Item for Clinicians in 2021

    Rossing, Peter & Epstein, M., 2022, In: American Journal of Medicine. 135, 5, p. 576-580 5 p.

    Research output: Contribution to journal › Review › Research › peer-review

  9. Published

    Multiomics signatures of type 1 diabetes with and without albuminuria

    Clos-Garcia, M., Ahluwalia, Tarun Veer Singh, Winther, S. A., Henriksen, P., Ali, M., Fan, Yong, Stankevic, Evelina, Lyu, Liwei, Vogt, J. K., Hansen, Torben, Legido-Quigley, C., Rossing, Peter & Pedersen, Oluf Borbye, 2022, In: Frontiers in Endocrinology. 13, 17 p., 1015557.

    Research output: Contribution to journal › Journal article › Research › peer-review

  10. Published

    Non-dipping and higher nocturnal blood pressure are associated with risk of mortality and development of kidney disease in type 1 diabetes

    Hjortkjær, H., Persson, F., Theilade, S., Winther, S. A., Tofte, N., Ahluwalia, Tarun Veer Singh & Rossing, Peter, 2022, In: Journal of Diabetes and its Complications. 36, 9, 6 p., 108270.

    Research output: Contribution to journal › Journal article › Research › peer-review

  11. Published

    Novel topical allogeneic bone-marrow-derived mesenchymal stem cell treatment of hard-to-heal diabetic foot ulcers: a proof of concept study

    Andersen, Jonas Askø, Rasmussen, A., Frimodt-Møller, M., Engberg, S., Steeneveld, E., Kirketerp-Møller, K., O’Brien, T. & Rossing, Peter, 2022, In: Stem Cell Research and Therapy. 13, 1, 280.

    Research output: Contribution to journal › Journal article › Research › peer-review

  12. Published

    Organic Anion Transporter Gene Variants Associated With Plasma Exposure and Long-Term Response to Atrasentan in Patients With Diabetic Kidney Disease

    Smeijer, J. D., Koomen, J. V., Kohan, D. E., McMurray, J. J. V., Bakris, G. L., Correa-Rotter, R., Hou, F. F., Kitzman, D. W., Makino, H., Mayer, G., Nowicki, M., Perkovic, V., Rossing, Peter, Tobe, S., Parving, H. H., de Zeeuw, D. & Heerspink, H. J. L., 2022, In: Clinical Pharmacology and Therapeutics. 112, 5, p. 1098-1107

    Research output: Contribution to journal › Journal article › Research › peer-review

  13. Published

    Precision diagnostic approach to predict 5-year risk for microvascular complications in type 1 diabetes

    Al-Sari, N., Kutuzova, Svetlana, Suvitaival, T., Henriksen, P., Pociot, Flemming, Rossing, Peter, McCloskey, D. & Legido-Quigley, C., 2022, In: EBioMedicine. 80, 104032.

    Research output: Contribution to journal › Journal article › Research › peer-review

  14. Published

    Quételet (body mass) index and effects of dapagliflozin in chronic kidney disease

    Chertow, G. M., Vart, P., Jongs, N., Langkilde, A. M., McMurray, J. J. V., Correa-Rotter, R., Rossing, Peter, Sjöström, C. D., Stefansson, B. V., Toto, R. D., Wheeler, D. C. & Heerspink, H. J. L., 2022, In: Diabetes, Obesity and Metabolism. 24, 5, p. 827-837 11 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  15. Published

    Randomized Controlled Trial of the Hemodynamic Effects of Empagliflozin in Patients With Type 2 Diabetes at High Cardiovascular Risk: The SIMPLE Trial

    Wolsk, E., Jürgens, M., Schou, Morten, Ersbøll, M., Hasbak, P., Kjær, Andreas, Zerahn, B., Brandt, N. H., Gæde, P. H., Rossing, Peter, Faber, Jens, Inzucchi, S. E., Kistorp, Caroline Michaela Nervil & Gustafsson, Finn, 2022, In: Diabetes. 71, 4, p. 812-820 9 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  16. Published

    Real life evaluation of sodium-glucose cotransporter 2 inhibition in type 1 diabetes and the risk of diabetic ketoacidosis

    Stougaard, E. B., Kristensen, Peter Lommer, Kielgast, U., Andersen, H. U., Hamid, Y., Gæde, P. H., Søndergaard, E., Dørflinger, G. H., Fjeldborg, K. K., Hansen, K. W., Thomsen, H. H., Al-Imar, T. M. J., Røder, M., Sridhar, V. S., Cherney, D., Rossing, Peter & Persson, F., 2022, In: Diabetes & vascular disease research. 19, 5, p. 14791641221130043

    Research output: Contribution to journal › Journal article › Research › peer-review

  17. Published

    Report from the CVOT Summit 2021: new cardiovascular, renal, and glycemic outcomes

    Schnell, O., Battelino, T., Bergenstal, R., Blüher, M., Böhm, M., Brosius, F., Carr, R. D., Ceriello, A., Forst, T., Giorgino, F., Guerci, B., Heerspink, H. J. L., Itzhak, B., Ji, L., Kosiborod, M., Lalić, N., Lehrke, M., Marx, N., Nauck, M., Rodbard, H. W. & 10 others, Rosano, G. M. C., Rossing, Peter, Rydén, L., Santilli, F., Schumm-Draeger, P., Vandvik, P. O., Vilsbøll, Tina, Wanner, C., Wysham, C. & Standl, E., 2022, In: Cardiovascular Diabetology. 21, 1, 50.

    Research output: Contribution to journal › Journal article › Research › peer-review

  18. Published

    Safety and efficacy of dapagliflozin in patients with focal segmental glomerulosclerosis: a prespecified analysis of the dapagliflozin and prevention of adverse outcomes in chronic kidney disease (DAPA-CKD) trial

    Wheeler, D. C., Jongs, N., Stefansson, B., Chertow, G. M., Greene, T., Hou, F. F., Langkilde, A. M., McMurray, J. J., Rossing, Peter, Nowicki, M., Wittmann, I., Correa-Rotter, R., Sjostrom, C. D., Toto, R. D., Heerspink, H. J. L. & DAPA-CKD Trial Comm Investigators, D. T. C. I., 2022, In: Nephrology Dialysis Transplantation. 37, 9, p. 1647–1656 10 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  19. Published

    Sodium–glucose cotransporter 2 inhibitors as adjunct therapy for type 1 diabetes and the benefit on cardiovascular and renal disease evaluated by Steno risk engines

    Stougaard, E. B., Rossing, Peter, Cherney, D., Vistisen, D. & Persson, F., 2022, In: Journal of Diabetes and its Complications. 36, 8, 108257.

    Research output: Contribution to journal › Journal article › Research › peer-review

  20. Published

    Sotagliflozin, a dual SGLT1 and SGLT2 inhibitor, reduces the risk of cardiovascular and renal disease as assessed by Steno Risk Engines in adults with type 1 diabetes

    Stougaard, E. B., Rossing, Peter, Vistisen, D., Banks, P., Girard, M., Davies, M. J. & Persson, F., 2022, In: Diabetologia. 65, SUPPL 1, p. S47 1 p.

    Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

  21. Published

    The Kidney Protective Effects of the Sodium–Glucose Cotransporter-2 Inhibitor, Dapagliflozin, Are Present in Patients With CKD Treated With Mineralocorticoid Receptor Antagonists

    Provenzano, M., Jongs, N., Vart, P., Stefánsson, B. V., Chertow, G. M., Langkilde, A. M., McMurray, J. J. V., Correa-Rotter, R., Rossing, Peter, Sjöström, C. D., Toto, R. D., Wheeler, D. C., Heerspink, H. J. L. & DAPA-CKD Trial Committees and Investigators, D. T. C. A. I., 2022, In: Kidney International Reports. 7, 3, p. 436-443

    Research output: Contribution to journal › Journal article › Research › peer-review

  22. Published

    The authors reply

    Kidney Disease: Improving Global Outcomes (KDIGO) Diabetes Work Group, K. D. I. G. O. (. D. W. G., 2022, In: Kidney International. 101, 2, p. 420-421 2 p.

    Research output: Contribution to journal › Comment/debate › Research › peer-review

  23. Published

    The effect of liraglutide on cardiac autonomic function in type 2 diabetes: A prespecified secondary analysis from the LIRAFLAME randomized, double-blinded, placebo-controlled trial

    Sivalingam, S., Hein Zobel, E., Hansen, C. S., Ripa, Rasmus Sejersten, von Scholten, B. J., Rotbain Curovic, V., Kjær, Andreas, Jensen, Jacob Kildevang, Hansen, T. W. & Rossing, Peter, 2022, In: Diabetes, Obesity and Metabolism. 24, 8, p. 1638-1642

    Research output: Contribution to journal › Letter › Research › peer-review

  24. Published

    The novel inflammatory biomarker GlycA and triglyceride-rich lipoproteins are associated with the presence of subclinical myocardial dysfunction in subjects with type 1 diabetes mellitus

    Puig-Jové, C., Julve, J., Castelblanco, E., Julián, M. T., Amigó, N., Andersen, H. U., Ahluwalia, Tarun Veer Singh, Rossing, Peter, Mauricio, D., Jensen, M. T. & Alonso, N., 2022, In: Cardiovascular Diabetology. 21, 257.

    Research output: Contribution to journal › Journal article › Research › peer-review

  25. Published

    The potential of GLP-1 receptor agonists in type 2 diabetes and chronic kidney disease: from randomised trials to clinical practice

    von Scholten, B. J., Kreiner, F. F., Rasmussen, S., Rossing, Peter & Idorn, T., 2022, In: Therapeutic Advances in Endocrinology and Metabolism. 13, p. 1-14

    Research output: Contribution to journal › Review › Research › peer-review

  26. Published

    Urinary Proteomics Identifies Cathepsin D as a Biomarker of Rapid eGFR Decline in Type 1 Diabetes

    Limonte, C. P., Valo, E., Drel, V., Natarajan, L., Darshi, M., Forsblom, C., Henderson, C. M., Hoofnagle, A. N., Ju, W., Kretzler, M., Montemayor, D., Nair, V., Nelson, R. G., O’toole, J. F., Toto, R. D., Rosas, S. E., Ruzinski, J., Sandholm, N., Schmidt, I. M., Vaisar, T. & 12 others, Waikar, S. S., Zhang, J., Rossing, Peter, Ahluwalia, Tarun Veer Singh, Groop, P. H., Pennathur, S., Snell-Bergeon, J. K., Costacou, T., Orchard, T. J., Sharma, K., de Boer, I. H. & Kidney Precision Medicine Project, K. P. M. P., 2022, In: Diabetes Care. 45, 6, p. 1416-1427 12 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

Previous 1...3 4 5 6 7 8 9 10 ...21 Next

ID: 12937790